Publication|Articles|October 10, 2025

Pharmacy Times

  • October 2025
  • Volume 91
  • Issue 10

FDA Approvals for September 2025

Author(s)PT Staff

Key Takeaways

  • Recent FDA approvals highlight advancements in oncology, focusing on therapies targeting specific genetic mutations for personalized treatment.
  • Expedited review processes by the FDA have enabled quicker access to innovative cancer treatments, improving patient outcomes.
SHOW MORE

Explore recent FDA-approved drugs from September 2025.

FDA Approvals

Articles in this issue

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME